Adverse events61

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 61

Type	Event	Organ system	Group	Affected	At risk
other	Anemia	Blood and lymphatic system disorders	Treatment (Nivolumab)	12	46
other	Edema limbs	General disorders	Treatment (Nivolumab)	3	46
other	Fatigue	General disorders	Treatment (Nivolumab)	21	46
other	Pruritus	Skin and subcutaneous tissue disorders	Treatment (Nivolumab)	7	46
other	Rash maculo-papular	Skin and subcutaneous tissue disorders	Treatment (Nivolumab)	8	46
other	Hyperthyroidism	Endocrine disorders	Treatment (Nivolumab)	7	46
other	Hypothyroidism	Endocrine disorders	Treatment (Nivolumab)	7	46
other	Diarrhea	Gastrointestinal disorders	Treatment (Nivolumab)	6	46
other	Nausea	Gastrointestinal disorders	Treatment (Nivolumab)	6	46
other	Alanine aminotransferase increased	Investigations	Treatment (Nivolumab)	3	46
other	Alkaline phosphatase increased	Investigations	Treatment (Nivolumab)	4	46
other	Aspartate aminotransferase increased	Investigations	Treatment (Nivolumab)	6	46
other	Creatinine increased	Investigations	Treatment (Nivolumab)	3	46
other	Lymphocyte count decreased	Investigations	Treatment (Nivolumab)	6	46
other	Platelet count decreased	Investigations	Treatment (Nivolumab)	6	46
other	White blood cell decreased	Investigations	Treatment (Nivolumab)	3	46
other	Investigations - Other, specify	Investigations	Treatment (Nivolumab)	3	46
other	Anorexia	Metabolism and nutrition disorders	Treatment (Nivolumab)	7	46
other	Hyperglycemia	Metabolism and nutrition disorders	Treatment (Nivolumab)	3	46
other	Hypoalbuminemia	Metabolism and nutrition disorders	Treatment (Nivolumab)	8	46

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04439214/events